Write in a clean editor, then format for European Heart Journal - Case Reports in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
European Heart Journal - Case Reports is a peer-reviewed journal published by Oxford University Press, covering Cardiac Valve Diseases and Treatments, Cardiac Arrhythmias and Treatments, Pericarditis and Cardiac Tamponade.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Author–year (OUP) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', European Heart Journal - Case Reports, 12(3), pp. 45–58.
Formats any DOI in the closest standard style — European Heart Journal - Case Reports has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Cardiac Valve Diseases and Treatments Cardiac Arrhythmias and Treatments Pericarditis and Cardiac Tamponade Cardiac Structural Anomalies and Repair Infective Endocarditis Diagnosis and Management |
| ISSN | 2514-2119 |
| Citation impact (2-yr) | 0.57 |
| h-index | 24 |
| i10-index | 224 |
| Total citations | 11,168 |
| Article processing charge | $574 |
| Open access | Yes |
| Top institutions publishing here | National Cerebral and Cardiovascular Center |
| Journal website | academic.oup.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: Venous thrombo-embolic events have been described in hospitalized patients with coronavirus disease 2019 (COVID-19), suggesting the presence of coagulopathy induced by the viral infection. To date, only rare cases of arterial thrombosis related to COVID-19 have been reported. CASE SUMMARY: A 54-year-old patient with an influenza-like illness 15 days earlier, which resolved, and no…
BACKGROUND: The aetiology of dilated cardiomyopathy (DCM) is highly heterogeneous including genetic and/or acquired (infective, toxic, immune, endocrine, and nutritional) factors. The major part of acquired DCM in developed countries is caused by either viral or autoimmune myocarditis. It is believed that the activation of the T-lymphocyte cell system is the major pathomechanism underlying autoimmune…
BACKGROUND: SARS-coronavirus-2 [coronavirus disease 2019 (COVID-19)] infection is a public health issue affecting millions of people. It started in Wuhan in China in December 2019 spreading rapidly worldwide. CASE SUMMARY: Three patients aged 51-84 developed a pericarditis related to COVID-19, associated for two of them with a myocarditis. Case 1 was a COVID-19 cardiac tamponade…
Abstract Background Novel coronavirus-19 disease (COVID-19) is associated with significant cardiovascular morbidity and mortality. To date, there have not been reports of sinus node dysfunction (SND) associated with COVID-19. This case series describes clinical characteristics, potential mechanisms, and short-term outcomes of COVID-19 patients who experience de novo SND. Case summary We present two cases of…
BACKGROUND: Immune checkpoint inhibitor (ICI)-related myocarditis is an uncommon but potentially fatal immune-related adverse event. Corticoid-resistant myocarditis induced by ICI is an important therapeutic challenge. CASE SUMMARY: Here, we present a case of steroid-refractory ICI-related myocarditis and myositis treated with abatacept and mycophenolate mofetil (MMF). A 57-year-old male with metastatic renal cell carcinoma was diagnosed…
